Allergy Therapeutics (LON:AGY) Share Price Crosses Below 200 Day Moving Average - Here's What Happened

Allergy Therapeutics plc (LON:AGY - Get Free Report)'s share price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 6.05 ($0.08) and traded as low as GBX 5.51 ($0.07). Allergy Therapeutics shares last traded at GBX 5.80 ($0.08), with a volume of 277,174 shares.

Allergy Therapeutics Price Performance

The business's fifty day moving average is GBX 6.32 and its two-hundred day moving average is GBX 6.09. The company has a market cap of £319.48 million, a P/E ratio of -6.26, a price-to-earnings-growth ratio of -30.70 and a beta of 1.40. The company has a debt-to-equity ratio of 835.48, a quick ratio of 1.48 and a current ratio of 1.63.

Allergy Therapeutics (LON:AGY - Get Free Report) last announced its quarterly earnings data on Monday, March 31st. The company reported GBX (0.23) ($0.00) earnings per share for the quarter. Allergy Therapeutics had a negative net margin of 72.86% and a negative return on equity of 266.59%. Equities analysts predict that Allergy Therapeutics plc will post -2.56 EPS for the current year.

Allergy Therapeutics Company Profile

Allergy Therapeutics is an international commercial biotechnology company focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.